Delivery Order SPE2DB22D3501-SPE2DB25FTU08

Award Date 12/11/24
Potential Completion Date 12/12/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTU08
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,088.36, is a Delivery Order under an Indefinite Delivery Contract (IDC) for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of December 12, 2024 and was awarded on December 11, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for supplying this critical medical commodity to support military healthcare programs and federal medical institutions under the DLA's extensive Troop Support Medical IDC, valued up to $999,999,999 through November 2026.

Generated 3/12/25, 10:07 AM